Anne Endmann

Title: Anne Endmann: Innovator in Bacterial Vector Technology

Introduction

Anne Endmann is a notable inventor based in Braunschweig, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of bacterial vectors for medical applications. Her innovative work focuses on the introduction of nucleic acids and proteins into animal cells, which has important implications for medical research and treatment.

Latest Patents

Anne Endmann holds a patent for a bacterial vector that relates to a combination of compounds for introducing nucleic acids and/or proteins into animal cells, tissues, organs, or organisms. This invention is designed for both in vitro and in vivo applications. The patent describes a combination that includes a genetically manipulated bacterial vector containing nucleic acid sequences with a transgene, along with a second component that facilitates the transcription and possibly translation of the transgene through controlled induction of the bacterial vector within the host.

Career Highlights

Throughout her career, Anne has worked with prestigious research institutions, including the Helmholtz Centre for Infection Research. Her work has been pivotal in advancing the understanding and application of bacterial vectors in medical science.

Collaborations

Anne has collaborated with esteemed colleagues such as Holger Loessner and Siegfried Weiss. Their joint efforts have contributed to the advancement of research in the field of infection biology and biotechnology.

Conclusion

Anne Endmann's innovative work in bacterial vector technology exemplifies the potential of biotechnology to transform medical treatments. Her contributions continue to influence the field and inspire future research endeavors.